Latest ELDN reports update at 2024-03-28: 20232022
Eledon Pharmaceuticals logo

Eledon Pharmaceuticals ELDN

$ 2.41 4.78%

Country

usaUSA

IPO year

2014

Industry

-

Stock Exchange

NASDAQ CAPITAL

CEO

-

Employees in the company

-

Shares

24.6 M

Market Cap[1]

$ 59.3 M

EBITDA (LTM)

$ -40.2 M

P/E (LTM)

-0.51

P/S (LTM)

-

EPS (LTM)

-2.23

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.